DASH-HF: DASH Diet in Heart Failure Outpatients

Sponsor
University of California, Davis (Other)
Overall Status
Recruiting
CT.gov ID
NCT05117086
Collaborator
American College of Cardiology (Other)
25
1
1
26
1

Study Details

Study Description

Brief Summary

The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DASH diet
N/A

Detailed Description

The overall objective of this pilot study is to refine the classification of the effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and laboratory correlative science approaches. The investigators will integrate the use and evaluation of DASH diet nutrition education in a clinical population using a pragmatic study approach. The investigators will assess dietary behavior change. The investigators will assess the medical effectiveness of the DASH diet to improve patient symptomology and clinical biomarkers. Exploratory investigations will involve metabolomics analyses of plasma samples for biomarker discovery of clinical phenotypes in HF patients, to characterize metabolic profiles related to dietary exposure.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single arm pragmatic trial with pre- and post- assessmentsSingle arm pragmatic trial with pre- and post- assessments
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
DASH Diet in Heart Failure Pilot Study - Integration and Effectiveness of Medical Nutrition Therapy Counseling on DASH Diet in the Management of Heart Failure Patients in an Academic Outpatient Cardiology Clinic
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dietary Intervention Arm

Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes. The focus will be on DASH diet implementation and adherence for management of heart failure. The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months). Outcome measures will be assessed at baseline, 3 and 6 months.

Behavioral: DASH diet
Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications

Outcome Measures

Primary Outcome Measures

  1. Dietary intake [Dietary intake at baseline]

    Dietary intake assessed by nutrient analysis of food records

  2. Dietary intake [Dietary intake at 3 months]

    Dietary intake assessed by nutrient analysis of food records

  3. Dietary intake [Dietary intake at 6 months]

    Dietary intake assessed by nutrient analysis of food records

  4. Diet score [Dietary intake at baseline]

    Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.

  5. Diet score [Dietary intake at 3 months]

    Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.

  6. Diet score [Dietary intake at 6 months]

    Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.

  7. Blood Pressure [Systolic and diastolic Blood Pressure at baseline]

    Blood Pressure assessed with systolic and diastolic pressure

  8. Blood Pressure [Systolic and diastolic Blood Pressure at 3 months]

    Blood Pressure assessed with systolic and diastolic pressure

  9. Blood Pressure [Systolic and diastolic Blood Pressure at 6 months]

    Blood Pressure assessed with systolic and diastolic pressure

Secondary Outcome Measures

  1. Heart Failure clinical marker [proBNP at baseline]

    proBNP will be assessed as a marker of severity of heart failure

  2. Heart Failure clinical marker [proBNP at 3 months]

    proBNP will be assessed as a marker of severity of heart failure

  3. Heart Failure clinical marker [proBNP at 6 months]

    proBNP will be assessed as a marker of severity of heart failure

  4. Patient report of HF symptoms [KCCQ at baseline]

    Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.

  5. Patient report of HF symptoms [KCCQ at 3 months]

    Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.

  6. Patient report of HF symptoms [KCCQ at 6 months]

    Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.

  7. Patient report of eating habit self efficacy [Eating Habits at Baseline]

    Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.

  8. Patient report of eating habit self efficacy [Eating Habits at 3 months]

    Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.

  9. Patient report of eating habit self efficacy [Eating Habits at 6 months]

    Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Heart Failure diagnosis

  • Guideline directed medical therapy optimization on stable regimen at least 30 days

Exclusion Criteria:
  • BMI < 18/5 kg/m squared

  • cardiac cachexia

  • end-stage renal disease or dialysis

  • acute inflammatory condition

  • uncontrolled arrhythmias or ischemia

  • status post heart transplant or implanted left ventricular assist device

Contacts and Locations

Locations

Site City State Country Postal Code
1 UC Davis Health Center - Cardiology Department Sacramento California United States 95817

Sponsors and Collaborators

  • University of California, Davis
  • American College of Cardiology

Investigators

  • Principal Investigator: Francene Steinberg, PhD, University of California, Davis

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT05117086
Other Study ID Numbers:
  • 1770356
First Posted:
Nov 11, 2021
Last Update Posted:
Feb 11, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2022